BCO Pilot Project: Difference between revisions

From BCOeditor Wiki
Jump to navigation Jump to search
Line 1: Line 1:
== Introduction ==
== Introduction ==
Overview: Briefly introduce the BioCompute Pilot Project, its purpose, and significance.
The BioCompute pilot project aims to increase adoption and awareness of the purpose of BioCompute Objects (BCOs) both within and outside of the FDA. This involves the collaboration among the BioCompute team, FDA and industry. It is significant in fostering mutual agreement on the usage of BCOs thereby streamlining and standardizing computational workflow submissions and reviews.  


Objectives: Outline the key goals and objectives of the project.
Participating sponsors will prepare and submit a computational workflow with a BioCompute Object (BCO) without any additional clarification, and FDA reviewers will review the BCO.
 
Scope: Define the scope of the project, including the types of data and analyses involved.


== BioCompute Objects (BCOs) ==
== BioCompute Objects (BCOs) ==
What is a BCO?: Provide a detailed explanation of BioCompute Objects, including their purpose and components.
A BioCompute Object (BCO) is an instance of the BioCompute standard and is a computational record of a bioinformatics pipeline. A BCO is not an analysis but is a record of which analyses were executed and in exactly which ways. In this way, a BCO acts as an interface for existing standards. A BCO contains all of the necessary information to repeat an entire pipeline from FASTQ to result and includes additional metadata to identify provenance and usage.
 
Structure of a BCO: Break down the sections of a BCO, such as Provenance Domain, Usability Domain, Extension Domain, Description Domain, and Execution Domain.
 
Examples: Provide examples of BCOs relevant to the pilot project.


== Pilot Project ==
== Pilot Project ==
Line 46: Line 40:


== References and Resources ==
== References and Resources ==
[https://wiki.biocomputeobject.org/White_paper White Paper]

Revision as of 11:42, 20 May 2024

Introduction

The BioCompute pilot project aims to increase adoption and awareness of the purpose of BioCompute Objects (BCOs) both within and outside of the FDA. This involves the collaboration among the BioCompute team, FDA and industry. It is significant in fostering mutual agreement on the usage of BCOs thereby streamlining and standardizing computational workflow submissions and reviews.

Participating sponsors will prepare and submit a computational workflow with a BioCompute Object (BCO) without any additional clarification, and FDA reviewers will review the BCO.

BioCompute Objects (BCOs)

A BioCompute Object (BCO) is an instance of the BioCompute standard and is a computational record of a bioinformatics pipeline. A BCO is not an analysis but is a record of which analyses were executed and in exactly which ways. In this way, a BCO acts as an interface for existing standards. A BCO contains all of the necessary information to repeat an entire pipeline from FASTQ to result and includes additional metadata to identify provenance and usage.

Pilot Project

Description

Documentation and Reporting

Standard Operating Procedures (SOPs)

Documentation Guidelines

Reporting Results

Compliance and Standards

Regulatory Compliance

Standards and Best Practices

Collaboration and Communication

Stakeholders

Communication Plan

Collaboration Tools

Challenges and Solutions

Common Challenges

Solutions and Mitigations

Future Directions

Next Steps

References and Resources

White Paper